The global robotic surgery market size was valued at USD 13.71 billion in 2025 and is projected to grow from USD 15.97 billion in 2026 to USD 54.20 billion by 2034, registering a CAGR of 16.5% during the forecast period from 2026 to 2034. North America dominated the robotic surgery market with a market share of 43.8% in 2025.
The global market for robotic surgery is anticipated to expand over the projection period due to increasing surgical processes being performed worldwide, owing to the surging cases of chronic illnesses. Moreover, there has been a rising demand for minimally invasive surgeries in recent years, as minimally invasive surgery offers several advantages, like lower postoperative complications, shorter hospital stays, faster recovery, and better cosmetic outcomes, thereby boosting robotic surgery market growth.
Download a Free Sample To learn more about this report,
Growing Shift Toward Multi-Platform and Advanced Robotic Surgery Systems
Hospitals are increasingly moving beyond single-platform robotic programs as newer systems enter clinical use and gain regulatory clearance. Modern platforms are being designed with modular arms, improved visualization, advanced instrumentation, digital connectivity, and flexible operating-room configurations. This broadening technology base gives healthcare providers more options when selecting systems for different procedures and surgical specialties. Greater competition can also encourage improvements in workflow, equipment design, service models, and instrument availability. As robotic surgery expands from established areas such as urology into general, colorectal, thoracic, and other procedures, hospitals are building more diversified robotic programs, strengthening demand for platforms, instruments, accessories, software, and supporting services.
December 2025 – The U.S. FDA cleared Medtronic’s Hugo robotic-assisted surgery system for urologic procedures and CMR Surgical’s Versius Plus system for general surgical applications.
Growing Robotic Procedure Volumes Increase Demand for Surgical Systems and Instruments
Increasing use of robotic assistance across general surgery, urology, gynecology, and other procedures is creating direct demand for surgical systems, instruments, accessories, and services. Hospitals can improve utilization of expensive robotic platforms when more surgeons and specialties perform procedures on the same installed equipment. Higher utilization also creates recurring demand because many robotic instruments and accessories must be replaced after defined usage periods. Growing procedure volumes can therefore encourage hospitals with established programs to purchase additional systems to increase operating-room capacity and reduce scheduling constraints. This creates a reinforcing demand cycle in which broader clinical adoption raises system utilization, supporting further equipment placements and recurring purchases throughout the robotic surgery ecosystem.
In January 2026, Intuitive reported that approximately 3.15 million da Vinci procedures were performed worldwide in 2025, around 18% more than approximately 2.68 million procedures in 2024.
High Capital and Recurring Costs Restrict Adoption Among Budget-Constrained Hospitals
High equipment and operating costs continue to restrict robotic surgery adoption, particularly among smaller hospitals and facilities with limited procedure volumes. Purchasing a robotic system requires considerable capital, while hospitals must also budget for instruments, accessories, maintenance, servicing, staff training, and operating-room requirements. Many instruments have limited usable lives and require replacement, creating recurring expenses after installation. Hospitals therefore need sufficient procedure volumes to spread these costs across more operations and justify investment. Facilities performing fewer suitable surgeries may find conventional laparoscopic equipment more economical. Although leasing and usage-based arrangements can reduce initial spending, the overall financial commitment can still delay purchasing decisions and limit penetration in cost-sensitive healthcare systems.
In March 2025, Intuitive reported that da Vinci systems generally sold for about USD 0.7 million to USD 3.1 million, while annual service contracts typically ranged from USD 100,000 to USD 225,000.
Public Healthcare Expansion Creates New Demand for Robot-Assisted Surgery
Expansion of robotic surgery within public healthcare systems creates an opportunity to move the technology from selected specialist centers into routine surgical care. Government-backed programs can support wider deployment by coordinating equipment procurement, surgeon training, clinical guidelines, operating-room planning, and patient access across hospital networks. Greater adoption can generate demand not only for robotic systems but also for instruments, maintenance, training, and digital support services. Suppliers that offer flexible purchasing models and systems suitable for multiple specialties can benefit as hospitals increase robotic capacity. Wider public-sector adoption may also expose more patients and clinicians to robotic procedures, creating a larger long-term installed base and supporting broader commercialization across healthcare systems.
In June 2025, NHS England projected that robot-assisted operations could increase from around 70,000 in 2023/24 to 500,000 annually by 2035, with robots supporting nine in ten keyhole surgeries.
System Reliability and Software Issues Increase Safety and Quality-Control Requirements
Maintaining reliable performance is a major challenge as robotic surgical systems become more dependent on software, sensors, displays, mechanical arms, cameras, and interconnected components. A malfunction during surgery can interrupt clinical workflows and may require troubleshooting, equipment replacement, or conversion to another surgical approach. Manufacturers therefore need extensive testing, software validation, post-market monitoring, maintenance, and rapid corrective processes throughout a system's lifecycle. Hospitals must also train surgical teams to recognize equipment problems and respond appropriately to technical alerts. Increasing technological complexity can make these responsibilities more demanding. Product recalls or software problems may additionally affect hospital confidence, making reliability, quality control, and responsive technical support important requirements for continued market expansion.
In February 2026, the U.S. FDA posted a Class II recall involving da Vinci 5 systems after a software-related error could cause user-interface crashes and loss of interaction at an affected display node.
Robotics Systems accounted for the largest share of the robotic surgery market, representing 32.5% of the total market in 2025, with a value of USD 4.46 billion. The segment is projected to expand at a CAGR of 16.2% during the forecast period. Its leading position is supported by the increasing adoption of advanced robotic platforms across hospitals and specialty surgical centers. Healthcare providers are investing in robotic systems to improve surgical precision, reduce complications, and shorten patient recovery times. Continuous technological advancements, better imaging capabilities, and growing acceptance of minimally invasive procedures have further strengthened demand. The rising number of complex surgeries and increasing healthcare investments also contribute to the sustained growth of this segment.
Laparoscopic robotic systems, orthopedic robotic systems, neurosurgical robotic systems, other robotic systems, and services are also contributing to the expansion of the market. Laparoscopic platforms continue to gain popularity because they support minimally invasive procedures across several specialties. Orthopedic robotic systems are witnessing strong adoption due to the growing volume of joint replacement surgeries and the need for improved implant positioning. Neurosurgical systems are becoming more important in delicate brain and spine procedures that require exceptional precision. Other robotic systems serve specialized surgical applications, while service offerings, including maintenance, software upgrades, and surgeon training, remain essential for ensuring efficient operation and long-term performance of robotic platforms.
Request Customizationto receive a tailored report.
Neurology is expected to register the fastest growth in the robotic surgery market, advancing at a CAGR of 17.8% during the forecast period. The segment is gaining strong momentum as robotic technologies improve the precision required for complex neurological procedures involving the brain and spine. Increasing cases of neurological disorders, greater demand for minimally invasive brain surgeries, and continuous improvements in navigation and imaging technologies are encouraging hospitals to adopt robotic-assisted systems. The growing availability of skilled neurosurgeons and expanding investments in advanced surgical infrastructure are also supporting the rapid development of this application area.
Orthopedics continues to hold a major position because robotic assistance improves the accuracy of joint replacement and orthopedic procedures while enhancing patient outcomes. Urology remains one of the earliest and most established fields for robotic-assisted surgery, supported by extensive clinical experience and surgeon familiarity. Gynecology is experiencing wider adoption as robotic systems enable precise and minimally invasive procedures for complex conditions. General surgery also benefits from robotic technology across a broad range of abdominal and gastrointestinal procedures, while other application areas are gradually adopting robotic solutions as healthcare providers continue expanding their surgical capabilities.
Hospitals dominated the robotic surgery market with a 76.9% market share in 2025, reaching a market value of USD 10.54 billion and growing at a CAGR of 16.2%. Hospitals remain the primary users of robotic surgical systems because they perform a high volume of complex procedures and possess the financial resources needed to invest in advanced technologies. Large healthcare institutions continue expanding robotic surgery programs to improve surgical precision, reduce patient recovery time, and strengthen their competitive position. The presence of experienced surgical teams, specialized operating rooms, and comprehensive patient care services further reinforces the dominance of hospitals in this market.
Ambulatory surgical centers are becoming increasingly important as healthcare systems shift toward cost-effective outpatient care and shorter hospital stays. These facilities are adopting robotic technologies to perform selected procedures with greater efficiency while improving patient convenience. Other end users, including specialty clinics and research institutions, are also integrating robotic surgery into their operations to support specialized treatments, clinical research, and advanced surgical training. Growing awareness of robotic-assisted procedures and continued technological improvements are expected to encourage broader adoption across these healthcare settings.
Speak to an Analystto discuss market opportunities.
North America dominated the robotic surgery market with a 43.8% market share in 2025, reaching a market value of USD 6 billion and is expected to expand at a CAGR of 15.9% during the forecast period. The region leads because of its well-developed healthcare infrastructure, high adoption of advanced medical technologies, and strong investment in robotic-assisted surgical procedures. Hospitals and specialized healthcare facilities continue to integrate robotic systems into routine clinical practice to improve surgical precision and patient outcomes. Growing awareness of minimally invasive procedures, increasing healthcare spending, and continuous product innovation by leading medical technology companies further strengthen the region’s leadership in the robotic surgery market.
The United States represents the largest contributor to the North American robotic surgery market due to its advanced healthcare ecosystem and widespread use of innovative surgical technologies. Hospitals and academic medical centers actively adopt robotic-assisted systems to improve clinical accuracy and enhance patient recovery. The country benefits from strong research activities, favorable reimbursement in selected procedures, and continuous collaboration between healthcare providers and medical device manufacturers. The presence of experienced surgeons, ongoing clinical training programs, and increasing demand for minimally invasive treatments continue to support the expansion of robotic surgery across multiple medical specialties.
Canada is steadily expanding its robotic surgery capabilities through continuous investments in modern healthcare infrastructure and advanced surgical technologies. Healthcare institutions are increasingly introducing robotic systems to improve treatment quality and reduce recovery time for patients undergoing complex procedures. Academic hospitals and research organizations are also supporting innovation by promoting surgeon training and evaluating new robotic applications. Government support for healthcare modernization and growing awareness among medical professionals about the clinical benefits of robotic-assisted surgery are encouraging broader adoption across different provinces and healthcare facilities.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia-Pacific is the fastest-growing region in the robotic surgery market and is projected to grow at a CAGR of 18.9% during the forecast period. The region accounted for 21.6% of the global market in 2025, with a market value of USD 2.96 billion. Rapid improvements in healthcare infrastructure, rising investments in advanced medical technologies, and increasing demand for minimally invasive surgical procedures are driving regional growth. Expanding healthcare access, growing medical tourism, and greater awareness of robotic-assisted surgery among healthcare providers are creating significant opportunities. Continuous expansion of hospitals and rising adoption of innovative surgical equipment are expected to further accelerate the robotic surgery market across the region.
Japan has established itself as an important market for robotic surgery because of its strong focus on medical innovation and precision healthcare. Healthcare providers are adopting robotic-assisted technologies to improve surgical efficiency while addressing the needs of an aging population that often requires advanced medical interventions. The country also benefits from close collaboration between hospitals, technology developers, and research institutions that continue to enhance robotic surgical capabilities. Ongoing investment in healthcare modernization and professional training is supporting wider acceptance of robotic systems across several medical specialties.
China is witnessing rapid growth in robotic surgery as healthcare providers continue investing in advanced surgical technologies and expanding hospital infrastructure. Increasing demand for high-quality medical services, rising healthcare expenditure, and government initiatives supporting healthcare modernization are encouraging wider adoption of robotic-assisted procedures. Domestic innovation and partnerships with international medical technology companies are strengthening product availability and technological development. As hospitals continue upgrading their surgical capabilities, robotic systems are becoming an increasingly important part of modern patient care across both public and private healthcare institutions.
Europe held a 27.4% share of the robotic surgery market in 2025, with a market value of USD 3.76 billion, and is projected to grow at a CAGR of 15.6% during the forecast period. The region continues to experience steady expansion due to increasing adoption of minimally invasive surgical procedures and strong emphasis on improving healthcare quality. Hospitals are investing in robotic-assisted technologies to enhance surgical precision, reduce complications, and improve patient outcomes. Supportive regulatory frameworks, continuous technological innovation, and growing collaboration between healthcare providers and medical device manufacturers are further contributing to the development of the robotic surgery market across Europe.
Germany is one of Europe's leading markets for robotic surgery because of its highly advanced healthcare infrastructure and strong focus on medical technology innovation. Hospitals and specialized surgical centers are increasingly integrating robotic systems into routine clinical practice to improve treatment quality and operational efficiency. The country also benefits from a highly skilled medical workforce and active research programs that encourage the adoption of next-generation surgical technologies. Continuous investment in healthcare modernization and strong cooperation between industry and research institutions continue to support market development.
The United Kingdom is experiencing increasing adoption of robotic-assisted surgery as healthcare providers seek to improve patient outcomes and expand access to minimally invasive procedures. Hospitals are strengthening their robotic surgery programs through investments in modern equipment and specialized surgeon training. Growing clinical evidence supporting robotic-assisted procedures is encouraging wider acceptance across multiple surgical specialties. Collaboration between healthcare organizations, universities, and medical technology companies is also helping to accelerate innovation and improve the overall quality of robotic surgical care throughout the country.
Latin America accounted for 4.2% of the robotic surgery market in 2025, with a market value of USD 0.58 billion, and is expected to grow at a CAGR of 14.8% during the forecast period. The region is gradually increasing its adoption of robotic-assisted surgical technologies as healthcare infrastructure continues to improve and access to advanced medical equipment expands. Private hospitals are leading investments in robotic systems to offer high-quality surgical services and attract more patients. Growing awareness of minimally invasive procedures and ongoing healthcare modernization initiatives are expected to support the continued expansion of the robotic surgery market across Latin America.
Brazil remains the leading market for robotic surgery in Latin America due to the expansion of private healthcare services and increasing investment in advanced surgical technologies. Hospitals are adopting robotic systems to improve clinical performance and meet the growing demand for minimally invasive treatments. Medical institutions are also placing greater emphasis on surgeon education and specialized training programs to ensure effective use of robotic platforms. Continued improvements in healthcare infrastructure and increasing collaboration with international medical technology providers are expected to strengthen the country's position in the regional market.
The Middle East and Africa represented 3% of the robotic surgery market in 2025, reaching a market value of USD 0.41 billion, and is projected to grow at a CAGR of 13.9% during the forecast period. The market is developing steadily as healthcare providers increase investments in advanced surgical technologies and modern hospital infrastructure. Growing awareness of robotic-assisted procedures and rising demand for high-quality healthcare services are encouraging adoption across selected medical centers. Governments and private healthcare organizations are also supporting healthcare modernization, creating favorable conditions for the long-term growth of the robotic surgery market.
The United Arab Emirates is emerging as an important market for robotic surgery through continuous investment in advanced healthcare infrastructure and medical innovation. Leading hospitals are adopting robotic-assisted surgical systems to strengthen specialized healthcare services and attract both domestic and international patients. The country is also emphasizing physician training, technology partnerships, and healthcare excellence to expand the use of robotic procedures across different specialties. Ongoing efforts to position the UAE as a regional healthcare destination are expected to encourage further adoption of robotic surgery technologies in the coming years.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
Aerosol Delivery Devices Market Size, Share, Growth, 2034
Artificial Cornea and Corneal Implant Market Size, Share, 2034
Active Wheelchair Market Size, Share, Growth, Forecast, 2034
Alpha Emitter Market Size, Share, Growth, Analysis, Report, 2034
Advanced Wound Care Market Size, Share, Growth, Analysis, 2034
Acute Wound Care Market Size, Share, Growth, Forecast, 2034
We are featured on:
sales@straitsresearch.com